Natural Alternatives International Inc (NAII) stock
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
$0.90−0.00 (-0.11%)
Close on Nov 18, 2026Market cap $19.90MP/E –Yield –
Natural Alternatives International r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2026 it was $2.30M, up 27.8% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $2.50M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.30M | +27.8% |
| FY2025 | Jun 30, 2025 | $1.80M | -5.3% |
| FY2024 | Jun 30, 2024 | $1.90M | -9.5% |
| FY2023 | Jun 30, 2023 | $2.10M | -16.0% |
| FY2022 | Jun 30, 2022 | $2.50M | +31.6% |
| FY2021 | Jun 30, 2021 | $1.90M | +5.6% |
| FY2020 | Jun 30, 2020 | $1.80M | 0.0% |
| FY2019 | Jun 30, 2019 | $1.80M | +20.0% |
| FY2018 | Jun 30, 2018 | $1.50M | -6.3% |
| FY2017 | Jun 30, 2017 | $1.60M | +45.5% |
| FY2016 | Jun 30, 2016 | $1.10M | 0.0% |
| FY2015 | Jun 30, 2015 | $1.10M | +10.0% |
| FY2014 | Jun 30, 2014 | $1.00M | -16.7% |
| FY2013 | Jun 30, 2013 | $1.20M | +9.1% |
| FY2012 | Jun 30, 2012 | $1.10M | +12.2% |
| FY2011 | Jun 30, 2011 | $980.00K | – |
See a number that looks wrong?